Press Release

Much Named 2020 USA Cannabis Law Firm of the Year by Global Health & Pharma


2 minute read

Much Named 2020 USA Cannabis Law Firm of the Year by Global Health & Pharma

Much is pleased to announce the firm's inclusion in this year's Global Health & Pharma (GHP) Medical Marijuana Awards. The firm earned its first national ranking as the 2020 USA Cannabis Law Firm of the Year.

Much's medical cannabis clients include health care providers, health systems, hospitals, medical professionals and providers, insurers and related patient groups. Drawing on the experience of the firm's health care attorneys, Much helps clients establish best practices in a broad range of operational, transactional and regulatory areas. This includes business counseling, government licensing, regulatory compliance, debt and equity financing, tax reporting, intellectual property prosecution and protection, marketing strategy and more.

Much also advises cannabis industry businesses, growers, dispensaries, retailers, banking institutions, individual investors and investment groups.

"Building our cannabis practice has been a top priority, which led to the growth of our Cannabis Law group. Our team includes outstanding attorneys from several practice groups within our firm," said principal Jonathan Sherman.

GHP hosts the Medical Marijuana Awards, which aim to recognize pioneering individuals and firms that are driving innovation and competition within their sectors of the cannabis industry.

"We look forward to growing our Cannabis Law group and expanding our knowledge and expertise," said associate Brian Crump. "As the industry evolves, our team will continue helping our clients make smart, practical decisions with long-term success in mind."

GHP's rankings are based on a research team's rigorous assessment. The research team makes its final judgment based on various criteria such as contributions to the global health care or pharmaceutical industries, longevity, diversification, sustained or continued growth, significant innovations and feedback from patients and customers. For more information, visit the GHP website.